Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2017
Jun. 30, 2017
Current assets :    
Cash $ 65,528 $ 14,326
Accounts receivable (net of allowance of $0 and $0, respectively) 491 382
Inventory 81,334 95,865
Other current assets 3,978 3,491
Total current assets 151,331 114,064
Total assets 151,331 114,064
Current liabilities:    
Accounts payable 209,755 205,961
Accrued expense-related party 198,000 180,000
Convertible notes payable - net of discount 244,151 151,020
Fair value of derivative liabilities 146,941 44,022
Short-term borrowings 2,500 3,096
Advance from shareholders 10,995 995
Total current liabilities 812,342 585,094
Commitments and contingencies
Stockholders' deficit:    
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 31,259,967 issued and outstanding as of September 30, 2017 and 29,724,432 outstanding as of June 30, 2017, respectively) 31,260 29,724
Additional paid in capital 3,668,724 2,880,467
Accumulated deficit (4,360,995) (3,381,221)
Total stockholders' deficit (661,011) (471,030)
Total Liabilities and Stockholders' Deficit $ 151,331 $ 114,064